An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan
Clinical trial NCT05791526 · COMPLETED
Trial details
- NCT number
- NCT05791526
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-19
- Primary completion
- 2025-12-09
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.